Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cellular Force That Drives Allergy and Asthma Can be Blocked by Interferon

Published: Friday, June 20, 2014
Last Updated: Friday, June 20, 2014
Bookmark and Share
Type I interferons block the development of allergy- and asthma-driving Th2 cells.

A mechanism that could underlie the development of cells that drive asthma and allergies has been uncovered by immunology researchers at UT Southwestern Medical Center.

Asthma and allergies are both driven by an inappropriate activation of the immune system, primarily a subtype of white blood cells known as T helper 2 cells, or Th2 cells. These cells are normally responsible for defense against parasites, but are also the main culprits behind the symptoms of asthma and allergies.

Dr. David Farrar, Associate Professor of Immunology and Molecular Biology at UT Southwestern, and his team found that the antiviral molecules known as type I interferons (IFNs) block the development of these allergy- and asthma-driving Th2 cells.

“The fact that interferon could stop the activation of these harmful cells was of particular interest because interferons are already approved by the Food and Drug Administration for the treatment of other diseases, such as multiple sclerosis and hepatitis,” said Dr. Farrar, who holds the J. Wayne Streilein, M.D. Professorship in Immunology.

The work, published in the Journal of Immunology, could eventually give rise to new therapies.

To demonstrate the prevalence of asthma, in the United States about 13 percent of adults - nearly 30 million people - have received a diagnosis of asthma. This frequency compares to 11 percent who have been diagnosed with heart disease and 8 percent who have had any form of cancer, according to the Centers for Disease Control and Prevention. Asthma is reported more often among women than men, among Caucasians, and in families with limited economic resources. Allergies, too, are prevalent, with more than 17.5 million people suffering from hay fever in the U.S.

The development of Th2 cells is stimulated by a particular immune molecule that triggers the production of a protein called GATA3. Frequently referred to as the master regulator of Th2 cell development, GATA3 turns on the genes that distinguish Th2 cells from other cell types, including other T cells.

Dr. Farrar’s group found that type I IFNs block this process by targeting a part of the GATA3 gene known as exon 1a and turning it off, thereby inhibiting the production of the GATA3 protein and, consequently, the development of Th2 cells.

“Targeting this pathway may lead to permanent tolerance of these cells to allergens,” said Dr. Farrar. “We are currently pursuing studies that may lead to clinical trials that will determine whether interferon can be used to treat allergic asthma patients.”

Dr. Farrar’s lab studies how a collective group of proteins called cytokines regulate immune responses. Type 1 interferon, the first immune cytokine discovered, is one of the very first lines of defense against viruses. The protein was initially identified based on its ability to inhibit influenza virus. Since then, scientists have discovered that almost any cell in the body can secrete interferon if it becomes infected with certain viruses, and that most cells can respond to interferon.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Boosting Gut Bacteria Defense System May Lead to Better Treatments
Life-threatening bloodstream infections reversed by enhancing a specific immune defense response.
Tuesday, June 09, 2015
Immunity Enzyme Defends Against Tuberculosis Infection
Study shows that cGAS enzyme is essential for defense against the tuberculosis bacteria.
Wednesday, June 03, 2015
Researchers Find New Mechanism That Controls Immune Responses
The findings appear online in the journal Science.
Friday, February 13, 2015
New And Beneficial Function Of Endogenous Retroviruses In Immune Response Identified
ERV play a critical role in the body’s immune defense against common bacterial and viral pathogens.
Friday, December 19, 2014
Scientists Identify New and Beneficial Function of Endogenous Retroviruses
Researchers found that ERV play a critical role in the body’s immune defense against common bacterial and viral pathogens.
Friday, December 19, 2014
UT Southwestern Researcher Selected for ASBMB Merck Award
Award recognizes Dr. Zhijian Chen’s outstanding contributions to research in biochemistry and molecular biology.
Friday, July 18, 2014
Study Identifies Potential New Strategy to Improve Odds of Corneal Transplant Acceptance
Study findings were reported in the December issue of the American Journal of Transplantation.
Tuesday, December 31, 2013
Identifying How Body Clock Affects Inflammation
UT Southwestern Medical Center researchers report that disrupting the light-dark cycle of mice increased their susceptibility to inflammatory disease.
Friday, November 08, 2013
Promising New Approach to Drug-Resistant Infections
A new type of antibiotic called a PPMO, which works by blocking genes essential for bacterial reproduction, successfully killed a multidrug-resistant germ common to health care settings.
Wednesday, October 16, 2013
Researchers Identify New Source of Powerful Immunity Protein
New cellular source for IFN-? that keeps viruses from replicating and stimulates the immune system.
Thursday, July 11, 2013
Dr. Bruce Beutler Elected to American Academy of Arts and Sciences
AAAS has elected Nobel Laureate Dr. Beutler of UT Southwestern Medical Center to membership.
Friday, April 26, 2013
Two UT Southwestern Scientists Honored as Rising Stars in Texas Research
Dr. Lora Hooper and Dr. Youxing Jiang are among the four chosen for the 2013 Edith and Peter O’Donnell Awards.
Thursday, December 13, 2012
UT Southwestern Researchers Identify Mechanism that Maintains Stem Cells
Immune-system receptor maintains stemness of normal adult stem cells and helps leukemia cells growth.
Tuesday, November 27, 2012
Molecular Biologist Wins Prestigious NAS Award
Dr. Chen will be honored on April 30 in a ceremony during the NAS’ 149th annual meeting.
Thursday, February 09, 2012
Internationally Acclaimed Immunologist to Lead New Center at UT Southwestern
Dr. Bruce Beutler has been appointed the founding director of a new Center for the Genetics of Host Defense.
Tuesday, August 30, 2011
Scientific News
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Iron Regulators Join War on Pathogens
Iron regulatory proteins (IRPs) play an important role in the body’s immune system.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!